Fate Therapeutics, Inc. (FATE)

Fate Therapeutics Revenue

Fate Therapeutics had revenue of $1.91M in the quarter ending June 30, 2025, a decrease of -71.84%. This brings the company's revenue in the last twelve months to $8.47M, down -31.23% year-over-year. In the year 2024, Fate Therapeutics had annual revenue of $13.63M, down -78.55%.

• Revenue (ttm): $8.47M
• Revenue Growth: -31.23%
• P/S Ratio: 18.01
• Revenue / Employee: $46,796
• Employees: 181
• Market Cap: 163.19M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	13.63M	-49.90M	-78.55%
Dec 31, 2023	63.53M	-32.77M	-34.03%
Dec 31, 2022	96.30M	40.45M	72.44%
Dec 31, 2021	55.85M	24.41M	77.66%
Dec 31, 2020	31.43M	20.75M	194.33%